Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 6.

Beresford, Mark, Casbard, Angela ORCID:, Hudson, Zoe, Carucci, Margherita, Ingarfield, Kate, Gee, Julia ORCID:, Smith, Joanna ORCID:, Kitson, Terri ORCID:, Alchami, Fouad, Madden, Tracie-Ann ORCID:, Hayward, Larrie, Hwang, David, Spensley, Saiqa, Waters, Simon, Wheatley, Duncan and Jones, Robert H. ORCID: 2023. Fulvestrant plus vandetanib versus placebo for the treatment of patients with metastatic breast cancer resistant to aromatase inhibitor therapy (FURVA): a multicentre, Phase 2, randomised controlled trial. BJC Reports 1 (1) , 13. 10.1038/s44276-023-00016-8

Kitson, Terri ORCID:, Osborne, Emma, Noble, Simon ORCID:, Pease, Nikki, Alikhan, Raza, Bryant, Catherine, Groves, Tristan, Wallace, Rebecca, Walker, Sarah, Seddon, Kathy, Smith, Deb, Raisanen, Lawrence, Smith, Joanna ORCID:, Thomas, Ian, Upton, Laura and Casbard, Angela ORCID: 2023. HIDDEN2: Study protocol for the hospital deep vein thrombosis detection study in patients with cancer receiving palliative care. BMJ Open 13 (9) , e073049. 10.1136/bmjopen-2023-073049

Noble, Simon I. ORCID:, Nelson, Annmarie ORCID:, Fitzmaurice, David, Bekkers, Marie-Jet, Baillie, Jessica ORCID:, Sivell, Stephanie ORCID:, Canham, Joanna ORCID:, Smith, Joanna D. ORCID:, Casbard, Angela ORCID:, Cohen, Ander, Cohen, David, Evans, Jessica, Fletcher, Kate, Johnson, Miriam, Maraveyas, Anthony, Prout, Hayley ORCID: and Hood, Kerenza ORCID: 2015. A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT). Health Technology Assessment 19 (83) , pp. 1-94. 10.3310/hta19830

Geldart, Thomas, Chester, John ORCID:, Casbard, Angela ORCID:, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna ORCID:, Cowles, Robert, Evans, Jessica and Griffiths, Gareth 2015. SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma. European Urology 67 (4) , pp. 599-602. 10.1016/j.eururo.2014.11.003

Noble, Simon, Smith, Joanna D., Baillie, Jessica, Baglin, T., Griffiths, Gareth O., Casbard, Angela, Cohen, Deborah, Fitzmaurice, D., Hood, Kerenza, Rose, P., Cohen, A., Johnson, Miriam, Maraveyas, A., Bell, John, Toone, H. and Nelson, Annmarie 2014. ALICAT: Anticoagulation length in cancer associated thrombosis - a mixed-methods feasibility study. Thrombosis Research 133 (Supp 2) , S220-S220. 10.1016/S0049-3848(14)50032-1

Smith, Joanna D. ORCID:, Baillie, Jessica ORCID:, Baglin, Trevor, Griffiths, Gareth O., Casbard, Angela C. ORCID:, Cohen, David, Fitzmaurice, David A., Hood, Kerenza ORCID:, Rose, Peter, Cohen, Alexander T., Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie ORCID: and Noble, Simon Ian Robert ORCID: 2014. A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study. Trials 15 (1) , 122. 10.1186/1745-6215-15-122

This list was generated on Tue Feb 27 04:38:28 2024 GMT.